OBJECTIVE To revise the 2000 Bureau of Health Professions Pharmacist Supply Model based on new data. DESIGN Stock-flow model. SETTING United States. PARTICIPANTS A 2004 estimate of active pharmacists reported by the Bureau of Labor Statistics was used to derive the base count for the 2007 supply model. INTERVENTIONS Starting with a 2004 base of active pharmacists, new graduates are adde...

Unexpected growth in medication use has escalated demand for pharmacists that has outpaced supply. Responses to the pharmacist shortage include larger workloads and greater use of pharmacist extenders and technology. As the profession has moved from a product orientation (dispensing medications) to a patient focus, clinical training requirements have expanded. However, structural and process ba...

Situation Analysis The goal of the development of the PCMHmodel is to provide a high level of care coordination, improve patient engagement, and focus on quality and improved patient outcomes. Although comprehensive and coordinatedmedicationmanagement is an integral component of the model, the inclusion of the pharmacist as a critical teammember is not always considered. Understanding the speci...

Pharmacists are expected to deliver pharmaceutical care, that is, to accept responsibility for patients' well-being by ensuring optimum outcomes of drug therapy. Therefore, their performance must be evaluated based on this expectation. The template should be a useful tool for assessing the extent to which clinical pharmacists' performance meets predefined practice standards. Its adaptability wi...

The purpose of this report is to: 1) Identify linkages across the EPA statements, Center for the Advancement of Pharmacy Education 2013 Educational Outcomes (CAPE 2013) and the Joint Commission of Pharmacy Practitioners' Pharmacist Patient Care Process (PPCP); 2) Provide ways EPA statements can be used to communicate core skills that are part of the entry-level pharmacist identity; 3) Suggest a...

A pharmacist–physician Antibiotic Support Team (AST) was designed and implemented to decrease overall costs and improve patient care by modifying antimicrobial regimens. During the pilot study program (from March to November 2000), 953 interventions were implemented with an overall estimated cost savings of $124,480. A pharmacist–physician team had a significant impact on economic outcomes. As ...

Pharmacist access to prescribing information may change.